最新的帖子

八月 24, 2020

How to Include Elastomers in the Nitrosamine Risk Assessment

Putting together a risk assessment for nitrosamines in your final drug product is an extensive undertaking. Many contributing factors need to be considered, such as the drug substance’s manufacturing process, excipients, buffers, water, production equipment and environment, transportation conditions, packaging, and more. Within this scope, primary packaging components, such as elastomeric closures, also could contribute nitrosamines or precursors.
Bettine Boltres

Dr. Bettine Boltres

Principal Scientific Affairs, Packaging & Delivery Systems

Categories

Search the Blog

Archive

  • 以前的博客
    By Your Side for Collaboration

    七月 24, 2019

    Scientific Insight Enables Risk Mitigation: Why West is By our Customers’ Side

    Fran DeGrazio

    Fran DeGrazio

    Vice President, Technical Services & Scientific Affairs

    West logo with Diamond

    三月 12, 2012

    Managing Total Cost of Ownership in a Changing Market

    West Author Logo

    Fran DeGrazio

    VP, Scientific Affairs & Technical Services